Publications by authors named "G-M Gilligan"
Article Synopsis
- * The National Lung Matrix Trial is the largest umbrella trial in NSCLC, utilizing next-generation sequencing to match patients with suitable targeted therapies based on their tumour's genetic profile, involving 19 drug-biomarker cohorts.
- * Though 5,467 patients were screened, only 2,007 qualified for the trial, with 302 receiving genotype-matched therapies; however, only a few drug-biomarker combinations showed meaningful clinical benefits, primarily in those with minimal tobacco exposure.
